TITAN Trial | Investigating the addition of apalutamide to androgen deprivation therapy
50:36
What they don't tell you about Androgen Deprivation Therapy (ADT, hormone therapy)
54:15
Focal Therapy with Professor Phillip Stricker AO
15:37
Choosing Systemic Therapy for Men with Metastatic Hormone Sensitive Prostate Cancer
10:18
ASCO GU 2022 - ERLEADA ® Real-World Study in Metastatic Castration-Sensitive Prostate Cancer or mCS
44:01
Theranostics & You | Riding the pipeline of personalisation in new nuclear medicines
6:12
Apalutamide, ADT Improve Outcomes in High-Risk Prostate Cancer Post-Surgery
30:39
Talk Like an Epidemiologist: Critical Appraisal
1:55:31